Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016, Article ID 9813253, 5 pages
http://dx.doi.org/10.1155/2016/9813253
Case Report

Metastasis of Pregnancy-Associated Breast Cancer (Suspected to Be Hereditary Breast and Ovarian Cancer) to the Brain, Diagnosed at 18 Weeks’ Gestation: A Case Report and Review of the Literature

1Department of Obstetrics and Gynecology, Fukuchiyama City Hospital, 231 Atsunaka-cho, Fukuchiyama, Kyoto 620-8505, Japan
2Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

Received 5 November 2015; Accepted 13 January 2016

Academic Editor: John P. Geisler

Copyright © 2016 Tomohiro Okuda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Barnes and L. A. Newman, “Pregnancy-associated breast cancer: a literature review,” Surgical Clinics of North America, vol. 87, no. 2, pp. 417–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Bando, “Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan,” Breast Cancer, vol. 21, no. 6, pp. 656–663, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Pascual, M. Uriarte, M. J. Agustín, V. Gimeno, I. Larrodé, and M. R. Abad, “Two cases of breast carcinoma during pregnancy and review of the literature,” Journal of Oncology Pharmacy Practice, 2015. View at Publisher · View at Google Scholar
  4. H. Lynch, H. Wen, Y. C. Kim et al., “Can unknown predisposition in familial breast cancer be family-specific?” Breast Journal, vol. 19, no. 5, pp. 520–528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. T. Lynch, W. A. Albano, and J. F. Lynch, “Genetic counseling, familial breast cancer, and the surgeon's responsibility,” Plastic and Reconstructive Surgery, vol. 66, no. 2, pp. 303–310, 1980. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Lynch, C. Synder, and S. M. Wang, “Considerations for comprehensive assessment of genetic predisposition in familial breast cancer,” Breast Journal, vol. 21, no. 1, pp. 67–75, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. T. R. Rebbeck, F. J. Couch, J. Kant et al., “Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2,” The American Journal of Human Genetics, vol. 59, no. 3, pp. 547–553, 1996. View at Google Scholar · View at Scopus
  8. S. A. Narod, D. Ford, P. Devilee et al. et al., “An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium,” The American Journal of Human Genetics, vol. 56, no. 1, pp. 254–264, 1995. View at Google Scholar
  9. R. Greenup, A. Buchanan, W. Lorizio et al., “Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort,” Annals of Surgical Oncology, vol. 20, no. 10, pp. 3254–3258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Prat, B. Adamo, M. C. U. Cheang, C. K. Anders, L. A. Carey, and C. M. Perou, “Molecular characterization of basal-like and non-basal-like triple-negative breast cancer,” Oncologist, vol. 18, no. 2, pp. 123–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Sørlie, R. Tibshirani, J. Parker et al., “Repeated observation of breast tumor subtypes in independent gene expression data sets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8418–8423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Sugano, S. Nakamura, J. Ando et al., “Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer,” Cancer Science, vol. 99, no. 10, pp. 1967–1976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. G. Guillem, W. C. Wood, J. F. Moley et al., “ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes,” Journal of Clinical Oncology, vol. 24, no. 28, pp. 4642–4660, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. D. Nelson, M. Pappas, B. Zakher, J. P. Mitchell, L. Okinaka-Hu, and R. Fu, “Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation,” Annals of Internal Medicine, vol. 160, no. 4, pp. 255–266, 2014. View at Google Scholar · View at Scopus
  15. Y. Segev, B. Rosen, J. Lubinski et al., “Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study,” Familial Cancer, vol. 14, no. 3, pp. 383–391, 2015. View at Publisher · View at Google Scholar
  16. B. Melichar, P. Fridrichová, Š. Lukešová et al., “Pathological complete response after primary chemotherapy in a mother and daughter with hereditary breastcarcinoma: two case reports,” European Journal of Gynaecological Oncology, vol. 29, no. 2, pp. 188–190, 2008. View at Google Scholar · View at Scopus
  17. E. H. Ernst, B. V. Offersen, C. Y. Andersen, and E. Ernst, “Legal termination of a pregnancy resulting from transplanted cryopreserved ovarian tissue due to cancer recurrence,” Journal of Assisted Reproduction and Genetics, vol. 30, no. 7, pp. 975–978, 2013. View at Publisher · View at Google Scholar · View at Scopus